Abstract
Anterior cruciate ligament (ACL) injury occurs soon after foot-strike. Cutting with a shallow flexed knee is considered a risk factor for ACL injury; however, how foot-strike patterns (forefoot strike [FFS] vs. rearfoot strike [RFS]) affect sagittal plane knee kinetics and kinematics after a foot-strike, is unknown. This study aimed to investigate the effect of foot-strike patterns on the temporal characteristics in sagittal plane knee kinetics and kinematics during cutting. Twenty-three males performed 45° cutting under RFS and FFS conditions. The marker position data on the lower limb, and the ground reaction force (GRF) data were collected and time-normalized (0%–100%) during the stance phase. The knee flexion angle, shank and GRF vector inclination angle relative to the global vertical axis, knee flexion/extension moment, and anterior/posterior component of GRF relative to the shank segment were calculated and compared between foot-strike patterns using statistical parametric mapping paired t-test (p<0.0071). The knee flexion angle was smaller in the RFS than in the FFS in the initial 40% of the stance phase. In the RFS condition, the GRF vector was directed anteriorly to the shank segment, and the knee extension moment was produced by GRF in 0%– 7% of the stance phase; these results were not observed in the FFS condition. These results suggest that compared to FFS, RFS induces a shallow flexed knee with an anterior-directed GRF component in the early stance phase, and might potentially provoke a risk of ACL injury.
Highlights
Sagittal plane knee mechanics differed between foot-strike patterns.
Shallower knee flexion occurred in rearfoot strike than in forefoot strike in cutting.
Ground reaction force vector directed anteriorly to shank axis in rearfoot strike.
Larger Knee extension moment occurred after initial contact in rearfoot strike.
Rearfoot strike had a potentially higher risk for ACL injury than forefoot strike.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by JSPS KAKENHI Grant Number 19K11491.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Ethics Committee of Osaka University Hospital (18082), and written informed consent was obtained from all participants.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
